---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-112629"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:12:47.549507+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Carisma Therapeutics announces director resignation and appointment of Sohanya Cheng

## Summary
- Michael Torok resigns from board effective Oct 31, 2024; cites other professional commitments, no disagreement.
- Sohanya Cheng elected director effective Oct 31, 2024 as Class I director until 2027 annual meeting.
- Cheng will serve on audit committee (Chair: Marella Thorell, Sanford Zweifach, Cheng).
- Compensation: $40K annual cash retainer, plus committee fees, and option for 38,700 shares at Oct 31 closing price, vesting monthly over 3 years.

## SEC filing metadata
- accession: 0001104659-24-112629
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/0001104659-24-112629-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/tm2426977d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-112629
- JSON: https://secwatch.observer/filing/0001104659-24-112629.json
- Plain text: https://secwatch.observer/filing/0001104659-24-112629.txt

## Key facts
- Executive change
  Sohanya Cheng was elected as Director at Carisma Therapeutics Inc..
  - Action: elected
  - Role: Director
  source text: On October 30, 2024, the Board elected Sohanya Cheng as a director of the Company, effective October 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/0001104659-24-112629-index.htm
- Executive change
  Michael Torok resigned as Director at Carisma Therapeutics Inc..
  - Action: resigned
  - Role: Director
  source text: On October 24, 2024, Michael Torok notified Carisma Therapeutics Inc. (the “Company”) of his decision to resign from the Company’s board of directors (the “Board”), effective October 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/0001104659-24-112629-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.